Literature DB >> 20522337

S-1 induces meibomian gland dysfunction.

Yukihiro Matsumoto, Murat Dogru, Enrique Adan Sato, Osama M A Ibrahim, Yukako Tatematsu, Yoko Ogawa, Kazuo Tsubota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20522337     DOI： 10.1016/j.ophtha.2010.01.048

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  3 in total

1.  Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1.

Authors:  Yoko Akune; Masakazu Yamada; Chika Shigeyasu
Journal:  Jpn J Ophthalmol       Date:  2018-06-21       Impact factor: 2.447

2.  Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen.

Authors:  A Karamitsos; V Kokkas; A Goulas; P Paraskevopoulos; K Gougoulias; V Karampatakis; K Boboridis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

3.  Quantitative Analysis of Changes to Meibomian Gland Morphology Due to S-1 Chemotherapy.

Authors:  Kazuyoshi Ohtomo; Reiko Arita; Rika Shirakawa; Tomohiko Usui; Hiroharu Yamashita; Yasuyuki Seto; Satoru Yamagami
Journal:  Transl Vis Sci Technol       Date:  2018-12-28       Impact factor: 3.283
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.